IMS Reports 'Strong Momentum' and 14% Growth

IMS Health, which recently announced its merger with VNU, has reported positive financial results for the second quarter of this year. Revenues were up 14% from the same time last year, with the US and Europe reporting the strongest growth.

The company's second quarter revenues were $433.3 million, compared with $379.6 million in the second quarter of 2004. Adjusted diluted earnings per share were $0.34 - an increase of 17% on the same period last year. Similarly, revenues for the first half of the year were up 14%, and adjusted diluted earnings per share were up 17%.

Adjusted net income was $77.8 million (up 12%) for the second quarter, and $145.9 million (up 11%) for the first six months. These results exclude merger-related costs.

'Our teams delivered double-digit reported revenue gains in all regions - the Americas, Europe and Asia Pacific,' explained David Carlucci, IMS CEO and President. 'IMS's outstanding performance demonstrates our continued success in delivering essential market intelligence to help clients with their most critical business decisions. Our momentum is strong, and we remain confident that we will achieve our financial objectives for the year.'

IMS announced its agreement to merge with VNU at the beginning of last week. The merger, which is expected to happen in the first quarter of 2006, remains subject to the approval of shareholders and regulatory conditions.

The company's web site is at www.imshealth.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• IMS Health Inc
• All news